Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | FPR1 | P21462 | 4/20 | 0.38 |
| ▸ | FPR2 | P25090 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 5/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 3/20 | 0.34 |
| ▸ | FNTB | P49356 | 3/20 | 0.34 |
| ▸ | CCKBR | P32239 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30590006 | 0.93 | CTSS (0.45) | CTSSCTSKFPR1FPR2CA2 | |
| SCHEMBL30480130 | 0.88 | CTSS (0.46) | CTSSCTSKFPR1FPR2REN | |
| SCHEMBL30590010 | 0.86 | FPR1 (0.42) | CTSSCTSKFPR1FPR2FNTA | |
| SCHEMBL30590004 | 0.84 | CTSS (0.46) | CTSSCTSKCA2FNTAFNTB | |
| SCHEMBL10606688 | 0.77 | CTSS (0.74) | CTSSCTSKCA2BACE1 | |
| SCHEMBL9611898 | 0.77 | CTSS (0.74) | CTSSCTSKCA2BACE1 | |
| SCHEMBL30312625 | 0.75 | CTSS (0.52) | CTSSCTSK | |
| SCHEMBL30814919 | 0.74 | PTGS1 (0.39) | CTSSCTSK | |
| SCHEMBL30480144 | 0.74 | CTSS (0.54) | CTSSCTSKCA2BACE1REN | |
| SCHEMBL30753792 | 0.74 | FNTA (0.45) | FPR1FPR2FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970551-B2 | Solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-04-30 | — | — | US | disclosed |
| US-11912791-B2 | Solution phase routes for Wnt hexapeptides | WNTRESEARCH AB (SE) | 2024-02-27 | — | — | US | disclosed |
| US-20230295232-A1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-09-21 | — | — | US | disclosed |
| EP-3841107-B1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-06-28 | — | — | EP | disclosed |
| EP-3613757-A1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | Wntresearch AB (SE) | 2020-02-26 | — | — | EP | disclosed |